Evidence map›Paper›PMID 36705287›Full record

ArticleJournal of managed care & specialty pharmacy2023

Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort study.

Ching-Yu Wang, Scott M Vouri, Haesuk Park, Coy D Heldermon, Joshua D Brown

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Mapping supportive-care evidence for febrile neutropenia prevention in breast cancer chemotherapy: a bibliometric analysis of long-acting G-CSF prophylaxis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  3. Advancing the conversation: 30 years of scholarship in managed care pharmacy.Journal of managed care & specialty pharmacy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ching-Yu WangDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy.
Scott M VouriDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy.
Haesuk ParkDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy.
Coy D HeldermonDivision of Hematology & Oncology, College of Medicine, University of Florida, Gainesville.
Joshua D BrownDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy.
Center for Drug Evaluation and Research · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBiosimilar PharmaceuticalsFebrile NeutropeniaFilgrastimNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsComparative Effectiveness ResearchGranulocyte Colony-Stimulating FactorHumansMalePolyethylene GlycolsRecombinant ProteinsRetrospective StudiesAntineoplastic AgentsBiosimilar PharmaceuticalsFilgrastimGranulocyte Colony-Stimulating FactorpegfilgrastimPolyethylene GlycolsRecombinant Proteins

Identifiers

PMID36705287
PMCPMC10387906
OpenAlexW4318263572

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.